Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Immusoft Awarded $8M in Funding from the California Institute for Regenerative Medicine (CIRM) for MPS I Clinical Program
Immusoft of CA, a wholly owned subsidiary of Immusoft, a clinical-stage cell therapy company dedicated […]
French Biotech Company AdipoPharma Secures Funding for Groundbreaking Diabetes Drug
AdipoPharma, a French biotech company developing a novel and promising type 2 diabetes drug, has […]
IASO Bio Raises Nearly $75 Million in Series C1 Funding
IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative […]
Eagle Genomics Disclose Funding from OMRON Ventures to Drive Sustainability Innovation in Microbiome R&D
Today, Eagle Genomics, the pioneering TechBio platform business applying network science to biology, disclosed additional […]
Alira Health Accelerates Global Growth and Secures Additional $58M in Funding
Alira Health, a global healthcare advisory, clinical research and technology company, announced it secured an […]
PVmed Raises US $14 Million Series A Funding
Perception Vision Medical Technologies (PVmed), a global artificial intelligence (AI) cancer treatment company, headquartered in […]
Anocca Secures €25 Million from the European Investment Bank to Support Development of T-cell Therapies for Cancer
Anocca, a fully integrated cell therapy biotechnology company, has announced that it has secured €25 […]
Biomica Raises $20 Million in a Funding Round to Advance its Pipeline of Microbiome-based Therapeutics
Biomica, a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene, has […]
Drug Safety Prediction AI Startup Quris Earns Additional Seed Funding Led by SoftBank Vision Fund 2
Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, has announced it has secured […]
Gilgamesh Pharmaceuticals Raises $39 Million in Series B Funding to Advance Mental Health Treatments
Gilgamesh Pharmaceuticals, a biotechnology company developing a portfolio of rapid-acting and durable treatments for depression […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more